Margetuximab
About
Therapy type: Hormone therapy
Therapy strategy: HER2 inhibition
Mappings
NCI Thesaurus: Margetuximab (coding:ncit:C91733)
RxNorm: margetuximab (coding:rxcui:2473851, coding:omop:739518)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | HER2-positive | Invasive Breast Carcinoma | Capecitabine, Margetuximab | |
| FDA (2) | HER2-positive | Invasive Breast Carcinoma | Eribulin, Margetuximab | |
| FDA (2) | HER2-positive | Invasive Breast Carcinoma | Gemcitabine, Margetuximab | |
| FDA (2) | HER2-positive | Invasive Breast Carcinoma | Margetuximab, Vinorelbine |